Skip to main content
Clinical Trials/NCT04199663
NCT04199663
Completed
Not Applicable

Secondary Prevention Treatments and Activities Post Myocardial Infarction Underlying the Risk of Recurrent Hard Cardiovascular Outcomes Associated With Socioeconomic Status

Karolinska Institutet0 sites30,191 target enrollmentJanuary 1, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Socioeconomic Status
Sponsor
Karolinska Institutet
Enrollment
30191
Primary Endpoint
first recurrent atherosclerotic cardiovascular disease event (rASCVD)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This is a nationwide cohort study on real-world patients (n≈30,000) surviving a first myocardial infarction (MI) 2006-2013 and alive to attend a routine 1-year follow-up. Associations between Socioeconomic Status (SES) and secondary preventive actions (SPAs) throughout the first year is studied and assessed as possible mechanisms underlying the increased risk of a first recurrent hard cardiocvascular (CV) outcome, recurrent atherosclerotic cardiovascular disease (rASCVD), in patients with low Socioeconomic Status during long-term follow-up (2006-2018).

Registry
clinicaltrials.gov
Start Date
January 1, 2006
End Date
December 31, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Per Svensson

Associate professor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Swedish resident
  • Alive and registered in The Swedish Websystem for Enhancement and Development of Evidence based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)'s secondary prevention subregistry between 1 January 2006 and 31 December 2013 at the 1-year-revisit

Exclusion Criteria

  • Age \>76 years at baseline
  • Missing data for disposable household income
  • History of MI, stroke, coronary artery bypass graft (CABG), or percutaneous coronary intervention (PCI) prior to the index MI
  • Not present in initial care registry (RiksHIA)
  • Date of index MI before 2004 or missing
  • revisit outside 13±2 month window post-MI

Outcomes

Primary Outcomes

first recurrent atherosclerotic cardiovascular disease event (rASCVD)

Time Frame: from date of 1-year visit post-MI (baseline) until date of outcome, censoring or study end (2018)

composite outcome including non-fatal MI (I210-I214, I219, I220, I221, I228 or I229) or coronary heart disease death (CHD) (I210-I214, I219, I220, I221, I228, I229, I461 or I469) or fatal or non-fatal ischemic stroke (I630-I635, I638 or I639) according to the International Classification of Diseases 10th edition (ICD-10)

Similar Trials